PMC7204768_01
Fluciclovine (FCV) PET/CT showing a tumorous mass with accumulating FCV in the liver (left) and in the lungs (right).
cro-0013-0431-g01.jpg
PMC7204768_01_cro-0013-0431-g01.jpg
F1
FCV in thoracic vertebrae 4 and 7, first sacral vertebra, and in the left ilium; tumorous lesion in the left lung obturating bronchi to segments 9 and 10 with higher cumulation of FCV (Fig. 1, left); three liver metastases, two of them with higher cumulation of FCV (Fig. 1, right). Focal accumulation of FCV in the prostate gland tumour; and no lymphadenopathy.
Octreotide SPECT/CT showing the same tumorous masses as in Fig. 1, accumulating octreotide - in the lungs (left) and in the liver (right).
cro-0013-0431-g02.jpg
PMC7204768_01_cro-0013-0431-g02.jpg
F2
The patient underwent octreotide SPECT/CT (Fig. 2) in December 2018 with the following results: pathological cumulation of radiopharmaceutical in all stages (after 4 and 24 h) found in the area of the left pulmonary hilus, in all three liver metastases, in the bone metastases in the fourth and seventh thoracic vertebrae, the third rib on the right, and in the left ilium.